Breaking News Instant updates and real-time market news.

PS

Pluralsight

$31.68

-0.2 (-0.63%)

16:13
02/13/19
02/13
16:13
02/13/19
16:13

Pluralsight reports Q4 EPS (9c), consensus (10c)

Reports Q4 revenue $67.3M, consensus $65.43M. "Pluralsight's fourth quarter capped off a milestone year for the company, highlighted by strong customer additions and 42% revenue growth. We achieved our seventh consecutive quarter of greater than 50% growth in B2B billings, while continuing to demonstrate the inherent levers to profitability in our model," said Aaron Skonnard, co-founder and CEO of Pluralsight.

  • 13

    Feb

  • 25

    Feb

PS Pluralsight
$31.68

-0.2 (-0.63%)

10/25/18
JPMS
10/25/18
NO CHANGE
Target $40
JPMS
Overweight
Pluralsight results can lift shares even in 'rough' market, says JPMorgan
Pluralsight's sales productivity "has hit an inflection point" and deals are coming in on higher price points, driving "exceptional" business-to-business again in Q3 with billings growth over 50%, JPMorgan analyst Sterling Auty tells investors in a post-earnings research note. He sees the set-up for the December quarter "offering a similar upside opportunity." And with cash flow turning positive, Pluralsight shares "can get a lift even in this rough market," contends Auty. He keeps an Overweight rating on the stock while trimming his price target to $40 from $44.
11/28/18
BARD
11/28/18
INITIATION
Target $28
BARD
Outperform
Pluralsight initiated with an Outperform at Baird
Baird initiated Pluralsight with an Outperform and $28 price target.
11/28/18
BARD
11/28/18
INITIATION
Target $28
BARD
Outperform
Pluralsight initiated with an Outperform at Baird
Baird analyst Jeffrey Meuler initiated Pluralsight with an Outperform rating and a price target of $28, saying the company is "extremely well positioned" to capture a "massive, growing, and underserved" market opportunity. The analyst believes that the management is correct in aggressively investing in the sales and go-to-market capabilities. Meuller is also positive in the company's "cost-effective content development" with added benefits from "scale and network effects". The analyst sees Pluralsight sustainably growing its revenues and billings by 30% or more.
11/29/18
11/29/18
INITIATION

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pluralsight (PS) initiated with an Outperform at Baird. 2. Expedia (EXPE) initiated with a Market Perform at Telsey Advisory. 3. Energy Transfer LP (ET) initiated with a Buy at Citi. 4. Skyline (SKY) initiated with a Neutral at Credit Suisse. 5. CBS (CBS) and Viacom (VIAB, VIA) were reinstated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

AAOI

Applied Optoelectronics

07:25
02/22/19
02/22
07:25
02/22/19
07:25
Downgrade
Applied Optoelectronics rating change  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

ANIK

Anika Therapeutics

$40.45

0.45 (1.13%)

07:24
02/22/19
02/22
07:24
02/22/19
07:24
Downgrade
Anika Therapeutics rating change  »

Anika Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOPE

Grand Canyon

$118.12

20.99 (21.61%)

07:24
02/22/19
02/22
07:24
02/22/19
07:24
Recommendations
Grand Canyon analyst commentary  »

Grand Canyon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIN

Dine Brands

$99.45

10.93 (12.35%)

07:23
02/22/19
02/22
07:23
02/22/19
07:23
Recommendations
Dine Brands analyst commentary  »

Dine Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFRX

InflaRx

$31.65

-0.83 (-2.56%)

07:23
02/22/19
02/22
07:23
02/22/19
07:23
Initiation
InflaRx initiated  »

InflaRx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNVGY

Lenovo

$0.00

(0.00%)

07:22
02/22/19
02/22
07:22
02/22/19
07:22
Upgrade
Lenovo rating change  »

Lenovo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GWPH

GW Pharmaceuticals

$143.86

-2.16 (-1.48%)

07:21
02/22/19
02/22
07:21
02/22/19
07:21
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ROKU

Roku

$51.47

-2.16 (-4.03%)

07:21
02/22/19
02/22
07:21
02/22/19
07:21
Downgrade
Roku rating change  »

Roku downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVI

Navient

$12.33

-0.32 (-2.53%)

07:20
02/22/19
02/22
07:20
02/22/19
07:20
Hot Stocks
Navient issues statement regarding Canyon nomination of four directors for board »

Navient issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNCR

Xencor

$32.22

-1.54 (-4.56%)

07:20
02/22/19
02/22
07:20
02/22/19
07:20
Downgrade
Xencor rating change  »

Xencor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

GBT

Global Blood Therapeutics

$50.04

-0.45 (-0.89%)

07:19
02/22/19
02/22
07:19
02/22/19
07:19
Initiation
Global Blood Therapeutics initiated  »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

FIT

Fitbit

$6.62

-0.03 (-0.45%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Downgrade
Fitbit rating change  »

Fitbit downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

STMP

Stamps.com

, FDX

FedEx

$182.28

0.52 (0.29%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Recommendations
Stamps.com, FedEx, UPS, Amazon.com analyst commentary  »

Stamps.com should return…

STMP

Stamps.com

FDX

FedEx

$182.28

0.52 (0.29%)

UPS

UPS

$111.76

0.68 (0.61%)

AMZN

Amazon.com

$1,619.84

-2.26 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 18

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

ARGX

Argenx

$122.20

-2.84 (-2.27%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$418.66

-3.9 (-0.92%)

07:17
02/22/19
02/22
07:17
02/22/19
07:17
Initiation
Regeneron initiated  »

Regeneron assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

  • 11

    Mar

  • 28

    Apr

  • 13

    May

BIIB

Biogen

$320.99

-14.02 (-4.18%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Initiation
Biogen initiated  »

Biogen assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

MGLN

Magellan Health

$70.81

-1.6 (-2.21%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Hot Stocks
Starboard to nominate full slate for election to Magellan Health board »

Starboard Value, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MO

Altria Group

$50.38

-0.14 (-0.28%)

07:14
02/22/19
02/22
07:14
02/22/19
07:14
Periodicals
Despite flavored vape ban, Juul sees $3.4B in revenue in 2019, Bloomberg says »

Despite the fact that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$127.56

-2.17 (-1.67%)

07:12
02/22/19
02/22
07:12
02/22/19
07:12
Initiation
Alexion initiated  »

Alexion initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

MCRB

Seres Therapeutics

$5.83

-0.07 (-1.19%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
Seres Therapeutics initiated  »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 18

    May

TREE

LendingTree

$310.22

-4.78 (-1.52%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 14

    Mar

  • 19

    Mar

ANAB

AnaptysBio

$64.87

-0.12 (-0.18%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
AnaptysBio initiated  »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$88.80

0.35 (0.40%)

07:10
02/22/19
02/22
07:10
02/22/19
07:10
Hot Stocks
United Airlines names Robert Rivkin as SVP and General Counsel »

United Airlines named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

RUTH

Ruth's Hospitality

$25.01

0.35 (1.42%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Ruth's Hospitality raises quarterly dividend to 13c per share »

Subsequent to the end of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MYGN

Myriad Genetics

$31.73

-0.19 (-0.60%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Myriad Genetics announces Vectra study data published »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 11

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.